
Sino Biological released its performance for the first half of the year, with a net profit attributable to the parent company of 67.6863 million yuan, a decrease of 4.59%

According to the Zhitong Finance APP, Sino Biological released its semi-annual report for 2025, showing an operating income of 324 million yuan, a year-on-year increase of 6.15%. The net profit attributable to shareholders of the listed company was 67.6863 million yuan, a year-on-year decrease of 4.59%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 33.1225 million yuan, a year-on-year increase of 31.85%. The basic earnings per share were 0.5565 yuan
According to the Zhitong Finance APP, Sino Biological (301047.SZ) released its semi-annual report for 2025, showing an operating income of 324 million yuan, a year-on-year increase of 6.15%. The net profit attributable to shareholders of the listed company was 67.6863 million yuan, a year-on-year decrease of 4.59%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 33.1225 million yuan, a year-on-year increase of 31.85%. The basic earnings per share were 0.5565 yuan

